OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Medical Genetics Part C-Seminars in Medical Geneti is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Bone health in RASopathies	83
Correction to “The Rise of the Genetic Counseling Profession in China”	80
Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic	51
C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease	49
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics	45
Catatonia responsive to corticosteroids in a patient with an SCN2A variant	37
Endocrinological manifestations in RASopathies	37
Health care satisfaction and medical literacy habits among caregivers of individuals with Down syndrome	36
Down syndrome across the lifespan	30
Evolution of Health Care in Turner Syndrome	26
Everyone Is a Tomato: Metagnostic Narratives of Genetic Revelation	25
Proximal urea cycle defects are challenging to detect with newborn screening: Results of a prospective pilot study using post‐analytical tools	24
Central nervous system involvement in individuals withRASopathies	24
	23
Table of Contents, Volume 196, Number 4, December 2024	22
A Genomic Analysis of Usher Syndrome: Population‐Scale Prevalence and Therapeutic Targets	22
Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation	22
Research Review of Myhre Syndrome	19
Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals	19
	18
Publication schedule for 2023	17
My Journey With Arthrogryposis and Some of the People Who Made a Difference	16
Retrospective review of the code status of individuals with Down syndrome during the COVID‐19 era	16
Co‐occurring conditions in Down syndrome: Findings from a clinical database	15
	14

Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype	13
Genetic testing and glomerular hematuria—A nephrologist's perspective	13
Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade‐long experience	13
Revisiting the Neuropsychological and Clinical Profile of Mosaic Turner Syndrome With a Ring X Chromosome	13
Unraveling the Mechanistic Spectrum of Myhre Syndrome: SMAD4 Signaling Disruption, Skeletal Phenotypes, and Translational Innovation	13
Children with Down syndrome who experience developmental skill loss, characterization, and phenomenology: A case series	12
Caregivers' concerns and supports needed to care for adults with Down syndrome	12
Family Lore, a Variant of Uncertain Significance, and CADASIL	10
Adult experiences in Beckwith–Wiedemann syndrome	10
Correction to “Experiences With Offering Pro Bono Medical Genetics Services in the West Indies: Benefits to Patients, Physicians, and the Community”	9
Normal joint range of motion in children with Down syndrome	9
Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosai	9
Occurrence of mosaic Down syndrome and prevalence of co‐occurring conditions in Medicaid enrolled adults, 2016–2019	9
Table of Contents, Volume 199, Number 1, March 2025	9
Cover Image, Volume 196, Number 1, March 2024	9
Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care	9
A plot TWIST	9
In Utero Therapies, the Next Frontier	8
Table of Contents, Volume 190, Number 2, June 2022	8
Disease mechanisms of monogenic congenital anomalies of the kidney and urinary tract	8
Whole‐genome sequencing holds the key to the success of gene‐targeted therapies	8
Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM1	8
Table of Contents, Volume 193, Number 4, December 2023	7
Cover Image, Volume 190, Number 3, September 2022	7
Parental Decision‐Making Following a Prenatal Diagnosis of Turner Syndrome: A Systematic Review	7
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease	7
Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re‐classification of an ARID1B missense variant	7
Ophthalmologic and neuro‐ophthalmologic findings in children with Down syndrome	7
Circles	6
Ode to Fiona: The Face of Fortitude in FBXL4 Deficiency	6
Cover Image, Volume 193, Number 1, March 2023	6
Genesis and genetics of a miracle	6
Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies	6
New prospectives on treatment opportunities in RASopathies	6
Data sharing to advance gene‐targeted therapies in rare diseases	6